DFX Intelligence
Data Factory
Reading the graph
Reading the graph
Private Equity
San Francisco, CA
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built and rebuilt at most every 15 minutes.
| Fund | Vintage | Lifecycle | ADV type | Form D sold | GAV | LPs |
|---|---|---|---|---|---|---|
| RM Special Holdings 8, LLC | 2022 | Unknown | Private Equity Fund | n/a | $1.2M | 0 |
| Redmile Biopharma Investments III, L.P. | 2021 | Unknown | Private Equity Fund | n/a | $1.2B | 0 |
| Redco II Master Fund, L.P. | 2021 | Active deployment | Hedge Fund | n/a | $1.5B | 0 |
| RM Special Holdings 4, LLC | 2021 | Unknown | Private Equity Fund | n/a | $44.9M | 0 |
| Redco I, L.P. | 2020 | Harvest | Hedge Fund | n/a | $109M | 0 |
| Company | State | Role | Control | Invested | Exited | Status |
|---|---|---|---|---|---|---|
| Ambrosia Biosciences Inc. | Co | minority | minority | Mar 31, 2026 | n/a | active |
| Bambusa Therapeutics, Inc. | Ma | minority | minority | Nov 17, 2025 | n/a | active |
| Clearlabs | n/a | unknown | unknown | n/a | n/a | active |
Also named here, with no published line of their own (reach them through the firm): Bryan Ranney Crapo (Chief Operating Officer), Michael Stewart Lee (Managing Director), Robert Carrington Faulkner (Managing Director), Amrit Nmn Nagpal (Managing Director), Jennifer Kate Ciresi (General Counsel And Chief Compliance Officer), Owen John Leary (Managing Director), Jeremy Charles Green (Managing Member), Josh Garcia (Chief Financial Officer).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan